Dexcom8-K: Digital transformationMay 14, 2026

Dexcom targets 10%+ annual revenue growth through 2030, signaling major strategic investments.

What happened

The company announced aggressive long-range financial targets, including sustained 10%+ annual revenue growth and an operating margin of 29-30% by 2030. Achieving these ambitious goals will necessitate significant investments in technology, data analytics, and operational efficiency to support innovation and scale.

Source

SEC EDGARMay 14, 2026

Current report (Form 8-K)

Dexcom 8-K

Filing excerpt

In addition, Dexcom announced new long-range financial targets at its 2026 Investor Day at the following levels:

sec.gov/Archives/edgar/data/1093557/000109355726000085/dxcm-20260514.htmRead the full source

Other signals in this filing (1)

Market expansionDexcom targets 10%+ annual revenue growth through 2030, signaling strategic expansion initiatives.Market expansionMay 14, 2026

Extracted by Autobound

From the Signal API record

Signal: 8-K: Digital transformation

What this signalsFilings often name leadership changes, deals and spending plans.

Form: 8-K
Fiscal year end: 05/14
Filed: May 14, 2026

More 8-K signals at other companies

SEC 8-K4D Molecular Therapeutics, Inc.4D Molecular Therapeutics initiates Phase 3 trial directly challenging competitor drug aflibercept.SEC 8-KSep 28, 2026
SEC 8-KAdeia Inc.Adeia Inc. appoints new CEO Dipti Vachani, effective October 12, 2026, replacing outgoing CEO Paul E. Davis.SEC 8-KSep 28, 2026
SEC 8-KAdicet Bio, Inc.Adicet Bio launching pivotal clinical trial in Q4 2026 after positive Phase 1 data for Prula-cel.SEC 8-KSep 28, 2026

The full record

From the Signal API record

Numbers

Percent: 10% (Minimum annual organic revenue growth target through 2030)

Details

CIK: 1093557
Accession number: 0001093557-26-000085
Filing year: 2026
Why it matters: Multi-year tech investment
Signal category: Strategic

Extraction

Confidence: Medium
Relevance: 80%
Sentiment: Positive
Detected: May 19, 2026
signal_type: sec-8k
signal_subtype: digitalTransformation

Use this data

Get every 8-K signal for Dexcom and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”
MCP setup guide
Send it to your own tools
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/39270b34-3049-4617-824c-2169dd019cf3 returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.

{
  "signal_id": "39270b34-3049-4617-824c-2169dd019cf3",
  "signal_type": "sec-8k",
  "signal_subtype": "digitalTransformation",
  "detected_at": "2026-05-19T10:14:18.577+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "detail": "The company announced aggressive long-range financial targets, including sustained 10%+ annual revenue growth and an operating margin of 29-30% by 2030. Achieving these ambitious goals will necessitate significant investments in technology, data analytics, and operational efficiency to support innovation and scale.",
    "metrics": {
      "pct": 0.1,
      "pct_context": "Minimum annual organic revenue growth target through 2030"
    },
    "summary": "Dexcom targets 10%+ annual revenue growth through 2030, signaling major strategic investments.",
    "excerpts": "In addition, Dexcom announced new long-range financial targets at its 2026 Investor Day at the following levels:",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "medium",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/dxcm-20260514.htm",
    "filing_date": "2026-05-14",
    "filing_year": 2026,
    "fiscal_year_end": "05/14",
    "sales_relevance": "Multi-year tech investment",
    "signal_category": "strategic"
  }
}

curl https://signals.autobound.ai/v1/signals/39270b34-3049-4617-824c-2169dd019cf3 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"dexcom.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.